|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E, Forman D, et al: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wilkes GM: Therapeutic options in the
management of colon cancer: 2005 update. Clin J Oncol Nurs.
9:31–44. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Winawer S, Fletcher R, Rex D, Bond J, Burt
R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, et al:
Gastrointestinal consortium panel: Colorectal cancer screening and
surveillance: Clinical guidelines and rationale-Update based on new
evidence. Gastroenterology. 124:544–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Collier FM, Gregorio-King CC, Gough TJ,
Talbot CD, Walder K and Kirkland MA: Identification and
characterization of a lymphocytic Rho-GTPase effector: Rhotekin-2.
Biochem Biophys Res Commun. 324:1360–1369. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei W, Chen H and Liu S: Knockdown of
Rhotekin 2 expression suppresses proliferation and invasion and
induces apoptosis in hepatocellular carcinoma cells. Mol Med Rep.
13:4865–4871. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liao YX, Zeng JM, Zhou JJ, Yang GH, Ding K
and Zhang XJ: Silencing of RTKN2 by siRNA suppresses proliferation,
and induces G1 arrest and apoptosis in human bladder cancer cells.
Mol Med Rep. 13:4872–4878. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gregorio-King CC, Gough T, Van Der Meer
GJ, Hosking JB, Waugh CM, McLeod JL, Collier FM and Kirkland MA:
Mechanisms of resistance to the cytotoxic effects of oxysterols in
human leukemic cells. J Steroid Biochem Mol Biol. 88:311–320. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aupeix K, Weltin D, Mejia JE, Christ M,
Marchal J, Freyssinet JM and Bischoff P: Oxysterol-induced
apoptosis in human monocytic cell lines. Immunobiology.
194:415–428. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang J, Chen JX, Chen L, Tang JY, Cui Z,
Liu CH and Wang Z: Metastasis associated in colon cancer 1 (MACC1)
promotes growth and metastasis processes of colon cancer cells. Eur
Rev Med Pharmacol Sci. 20:2825–2834. 2016.PubMed/NCBI
|
|
10
|
Chen M, Bresnick AR and O'Connor KL:
Coupling S100A4 to Rhotekin alters Rho signaling output in breast
cancer cells. Oncogene. 32:3754–3764. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan J, Ma LJ, Xia SJ, Yu L, Fu Q, Wu CQ,
Huang XH, Jiang JM and Tang XD: Association between clinical
characteristics and expression abundance of RTKN gene in human
bladder carcinoma tissues from Chinese patients. J Cancer Res Clin
Oncol. 131:157–162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fu Q, Yu L, Liu Q, Zhang J, Zhang H and
Zhao S: Molecular cloning, expression characterization, and mapping
of a novel putative inhibitor of rho GTPase activity, RTKN, to
D2S145-D2S286. Genomics. 66:328–332. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yildiz B, Etiz D, Dal P, Junushova B,
Pasaoglu O, Yilmaz E, Erkasap S and Dincer M: Tumor deposits:
Prognostic significance in gastric cancer patients. J BUON.
21:1476–1481. 2016.PubMed/NCBI
|
|
14
|
Wang S, Bian C, Yang Z, Bo Y, Li J, Zeng
L, Zhou H and Zhao RC: miR-145 inhibits breast cancer cell growth
through RTKN. Int J Oncol. 34:1461–1466. 2009.PubMed/NCBI
|
|
15
|
Sevli S, Uzumcu A, Solak M, Ittmann M and
Ozen M: The function of microRNAs, small but potent molecules, in
human prostate cancer. Prostate Cancer Prostatic Dis. 13:208–217.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi L, Wu YX, Yu JH, Chen X, Luo XJ and
Yin YR: Research of the relationship between β-catenin and
c-myc-mediated Wnt pathway and laterally spreading tumors
occurrence. Eur Rev Med Pharmacol Sci. 21:252–257. 2017.PubMed/NCBI
|
|
17
|
Hua F, Liu S, Zhu L, Ma N, Jiang S and
Yang J: Highly expressed long non-coding RNA NNT-AS1 promotes cell
proliferation and invasion through Wnt/β-catenin signaling pathway
in cervical cancer. Biomed Pharmacother. 92:1128–1134. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Q, Lou Y, Bai X and Liang T: EPAS1
promote tumor progression by interacting with Wnt/β-catenin
signaling in pancreatic cancer. HPB. 18:e350–e351. 2016. View Article : Google Scholar
|
